Journal of the Korean Association of Oral and Maxillofacial Surgeons

  • 제36권6호
  • /
  • Pages.533-537
  • /
  • 2010
  • /
  • 2234-7550(pISSN)
  • /
  • 2234-5930(eISSN)
대한구강악안면외과학회 (The Korean Association of Oral and Maxillofacial Surgeons)
권호 표지
DOI QR코드

DOI QR Code

Sialadenoma papilliferum: 증례보고 및 면역조직화학적 고찰

Sialadenoma papilliferum: a case report and immunohistochemical study review

  • Byun, June-Ho (Department of Oral and Maxillofacial Surgery, School of Medicine, Institute of Health Sciences, Gyeongsang National University) ;
  • Kim, Dong-Chul (Department of Pathology, School of Medicine, Gyeongsang National University) ;
  • Go, Gyung-Hyuck (Department of Pathology, School of Medicine, Gyeongsang National University) ;
  • Park, Bong-Wook (Department of Oral and Maxillofacial Surgery, School of Medicine, Institute of Health Sciences, Gyeongsang National University)
  • 투고 : 2010.08.27
  • 심사 : 2010.12.17
  • 발행 : 2010.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Sialadenoma papilliferum (SP) is a rare benign neoplasm that normally arises from the minor salivary glands, particularly in the palate. SP is normally encountered in older men with an exophytic papillary surface growth. In the present study, an SP of the hard palate of a 69-year-old woman was examined immunohistochemically. Myoepithelial cell markers, such as S-100, smooth muscle actin and vimentin, were observed in the basal or luminal layer of tumor cells, indicating that myoepithelial cells participate in the pathogenesis of SP. In addition, cytokeratin 7 was also strongly detected in the tumor cells, suggesting that excretory ductal epithelial cells have a role in its histogenesis. A review of the literature of immunohistochemical studies on SP showed that the expression and co-expression of cytokeratins and myoepithelial cell markers have been reported in tumor cells. These results suggested that excretory duct cells and myoepithelial cells participate in the pathogenesis of SP.

키워드

참고문헌

  1. Mahajan D, Khurana N, Setia N. Sialadenoma papilliferum in a young patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e51-4.
  2. Shimoda M, Kameyama K, Morinaga S, Tanaka Y, Hashiguchi K, Shimada M, et al. Malignant transformation of sialadenoma papilliferum of the palate: a case report. Virchows Arch 2004; 445:641-6. https://doi.org/10.1007/s00428-004-1091-4
  3. Abrams AM, Finck FM. Sialadenoma papilliferum. A previously unreported salivary gland tumor. Cancer 1969;24:1057-63. https://doi.org/10.1002/1097-0142(196911)24:5<1057::AID-CNCR2820240529>3.0.CO;2-L
  4. Crocker DJ, Christ TF, Cavalaris CJ. Sialadenoma papilliferum: report of case. J Oral Surg 1972;30:520-1.
  5. Markopoulos A, Kayavis I, Papanayotou P. Sialadenoma papilliferum of the oral cavity: report of a case and literature review. J Oral Maxillofac Surg 1997;55:1181-4. https://doi.org/10.1016/S0278-2391(97)90305-0
  6. Ubaidat MA, Robinson RA, Belding PJ, Merryman DJ. Sialadenoma papilliferum of the hard palate: report of 2 cases and immunohistochemical evaluation. Arch Pathol Lab Med 2001;125:1595-7.
  7. Fantasia JE, Nocco CE, Lally ET. Ultrastructure of sialadenoma papilliferum. Arch Pathol Lab Med 1986;110:523-7.
  8. Freedman PD, Lumerman H. Sialadenoma papilliferum. Oral Surg Oral Med Oral Pathol 1978;45:88-94. https://doi.org/10.1016/0030-4220(78)90228-1
  9. Maiorano E, Favia G, Ricco R. Sialadenoma papilliferum: an immunohistochemical study of five cases. J Oral Pathol Med 1996; 25:336-42. https://doi.org/10.1111/j.1600-0714.1996.tb00273.x
  10. Nakahata A, Deguchi H, Yanagawa T, Yoshida H, Sato M, Hayashi Y. Coexpression of intermediate-sized filaments in sialadenoma papilliferum and other salivary gland neoplasms. J Oral Pathol Med 1990;19:313-8. https://doi.org/10.1111/j.1600-0714.1990.tb00851.x
  11. Shirasuna K, Watatani K, Miyazaki T. Ultrastructure of a sialadenoma papilliferum. Cancer 1984;53:468-74. https://doi.org/10.1002/1097-0142(19840201)53:3<468::AID-CNCR2820530317>3.0.CO;2-R
  12. Bobos M, Hytiroglou P, Karkavelas G, Papakonstantinou C, Papadimitriou CS. Sialadenoma papilliferum of bronchus. Virchows Arch 2003;443:695-9. https://doi.org/10.1007/s00428-003-0879-y
  13. Gomes AP, Sobral AP, Loducca SV, de Araujo VC. Sialadenoma papilliferum: immunohistochemical study. Int J Oral Maxillofac Surg 2004;33:621-4. https://doi.org/10.1016/j.ijom.2003.10.019
  14. Rouse RV, Soetikno RM, Baker RJ, Barnard IC, Triadafilopoulos G, Longacre TA. Esophageal submucosal gland duct adenoma. Am J Surg Pathol 1995;19:1191-6. https://doi.org/10.1097/00000478-199510000-00009
  15. Pimentel MT, Lopez Amado M, Garcl′a Sarandeses A. Recurrent sialadenoma papilliferum of the buccal mucosa. J Laryngol Otol 1995;109:787-90.
  16. Rennie JS, MacDonald DG, Critchlow HA. Sialadenoma papilliferum. A case report and review of the literature. Int J Oral Surg 1984;13:452-4. https://doi.org/10.1016/S0300-9785(84)80074-5
  17. van der Wal JE, van der Waal I. The rare sialadenoma papilliferum. Report of a case and review of the literature. Int J Oral Maxillofac Surg 1992;21:104-6. https://doi.org/10.1016/S0901-5027(05)80543-0
  18. Hara K, Ito M, Takeuchi J, Iijima S, Endo T, Hidaka H. Distribution of S-100b protein in normal salivary glands and salivary gland tumors. Virchows Arch A Pathol Anat Histopathol 1983;401:237-49. https://doi.org/10.1007/BF00692648
  19. de Araujo VC, Carvalho YR, de Araujo NS. Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study. Oral Surg Oral Med Oral Pathol 1994;77:387-91. https://doi.org/10.1016/0030-4220(94)90201-1
  20. Furuse C, Sousa SO, Nunes FD, Magalhães MH, Araujo VC. Myoepithelial cell markers in salivary gland neoplasms. Int J Surg Pathol 2005;13:57-65. https://doi.org/10.1177/106689690501300108